Tech Company Financing Transactions

Beren Therapeutics Funding Round

Beren Therapeutics, based in Thousand Oaks, scored $300 million in funding from Eisai, Founders Fund and Hercules Capital.

Transaction Overview

Company Name
Announced On
6/10/2026
Transaction Type
Debt
Venture Equity
Amount
$300,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate commercial readiness activities for its lead asset ahead of its upcoming regulatory target date, expand diagnostic integration networks, and build a long-term patient access and family support program.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2101 Corporate Center Dr
Thousand Oaks, CA 91320
USA
Phone
Undisclosed
Email Address
Overview
Beren is public benefit corporation building a new model of integrated, patient-aligned biotechnology. Beren was designed from inception to understand the needs of patient communities, healthcare providers, and health systems in order to identify, develop, and provide access to transformative medicines.
Profile
Beren Therapeutics LinkedIn Company Profile
Social Media
Beren Therapeutics Company Twitter Account
Company News
Beren Therapeutics News
Facebook
Beren Therapeutics on Facebook
YouTube
Beren Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jason Camm
  Jason Camm LinkedIn Profile  Jason Camm Twitter Account  Jason Camm News  Jason Camm on Facebook
Chief Financial Officer
Aaron Ondrey
  Aaron Ondrey LinkedIn Profile  Aaron Ondrey Twitter Account  Aaron Ondrey News  Aaron Ondrey on Facebook
Chief Medical Officer
Alex Gold
  Alex Gold LinkedIn Profile  Alex Gold Twitter Account  Alex Gold News  Alex Gold on Facebook
Chief Scientific Officer
Rajinder Singh
  Rajinder Singh LinkedIn Profile  Rajinder Singh Twitter Account  Rajinder Singh News  Rajinder Singh on Facebook
Chief Technical Officer
Magali Hickey
  Magali Hickey LinkedIn Profile  Magali Hickey Twitter Account  Magali Hickey News  Magali Hickey on Facebook
Vice President
Cathy Traz
  Cathy Traz LinkedIn Profile  Cathy Traz Twitter Account  Cathy Traz News  Cathy Traz on Facebook
Vice President
Irene von Hennigs
  Irene von Hennigs LinkedIn Profile  Irene von Hennigs Twitter Account  Irene von Hennigs News  Irene von Hennigs on Facebook
VP - Bus. Development
Bennett Smith
  Bennett Smith LinkedIn Profile  Bennett Smith Twitter Account  Bennett Smith News  Bennett Smith on Facebook
VP - General Counsel
Peter Cicala
  Peter Cicala LinkedIn Profile  Peter Cicala Twitter Account  Peter Cicala News  Peter Cicala on Facebook
VP - Human Resources
Heather McCuenq
  Heather McCuenq LinkedIn Profile  Heather McCuenq Twitter Account  Heather McCuenq News  Heather McCuenq on Facebook
VP - Regulatory Affairs
Jennifer Spinella
  Jennifer Spinella LinkedIn Profile  Jennifer Spinella Twitter Account  Jennifer Spinella News  Jennifer Spinella on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/10/2026: Alta Ares venture capital transaction
Next: 6/10/2026: Uncovr venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary